CAMBRIDGE, Mass. (AP) 鈥� CAMBRIDGE, Mass. (AP) 鈥� Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $18.2 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of 15 cents per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
The genome editing company posted revenue of $11.9 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $1.9 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/EDIT
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
